SCoV-2 Ag DetectTM Rapid Test
New!
Detect COVID-19 Delta Variant with InBios POC Antigen Test
Initial lab studies show SCoV-2 Ag Detect™ Rapid Test will detect the Delta variant FDA Emergency Use Authorized & CE Marked
Patent pending design: direct nasal swabs
New!
Detect COVID-19 Delta Variant with InBios POC Antigen Test
Initial lab studies show SCoV-2 Ag Detect™ Rapid Test will detect the Delta variant FDA Emergency Use Authorized & CE Marked
Patent pending design: direct nasal swabs
Location: United States, Washington, Seattle
Employees: 51-200
Total raised: $16M
Founded date: 1996
Funding Rounds 1
| Date | Series | Amount | Investors |
| 03.12.2024 | - | $16M | - |
Mentions in press and media 10
| Date | Title | Description |
| 03.12.2024 | Seattle's InBios Secures BARDA-funded Project Award Valued Over $16M to Enhance Rapid Biothreat Test | InBios International Inc. InBios International Inc., a leading developer of diagnostics for infectious diseases, announced that it received a project award valued at $16,511,354 to optimize, complete performance validation, and file for FDA... |
| 05.09.2024 | InBios Receives FDA 510(k) Clearance for COVID-19 POC Antigen Detection Test | InBios International Inc., a leading developer of diagnostic tests for emerging infectious diseases, announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its SCoV-2 Ag Detect Rapid Test. SEA... |
| 14.08.2024 | InBios Launches an In Vitro Diagnostic Test for Strongyloidiasis Providing Fast Results | Strongy Detect IgG ELISA InBios International Inc., a leading developer and manufacturer of diagnostic tests for emerging infectious diseases and biothreats, is launching a new in vitro serological ELISA kit for presumptive clinical laborat... |
| 01.03.2023 | FDA Grants First Marketing Rights for Anthrax Point-of-Care Test to InBios | Active Anthrax Detect™ Plus Rapid Test "A fast, accurate test is needed to prepare for a potential bioterrorism attack or outbreak. Our test could play a critical role in thwarting any suspicious activities early on.” SEATTLE (PRWEB) M... |
| 15.11.2022 | InBios Awarded Funding for Lyme Disease Diagnostic from HHS, Cohen Foundation | This proposed platform uniquely addresses several needs in the Lyme diagnostic field and generates a unique ‘fingerprint’ of reactivity for each patient specimen. SEATTLE (PRWEB) November 15, 2022 InBios International Inc., a leading develo... |
| 30.11.2021 | InBios Receives FDA EUA for Home Use Antigen Test for COVID-19 | Designed to be extremely simple to use for consumers who are not familiar with self-testing, the SCoV-2 Ag Detect Rapid Self-Test, will soon be available for purchase without a prescription in major retail stores and online through e-commer... |
| 28.10.2021 | InBios Receives FDA EUA for COVID-19 Neutralizing Antibody ELISA | The SCoV-2 Detect Neutralizing Ab ELISA provides an important research tool for better understanding of the existence of neutralizing antibodies and COVID immunity. SEATTLE (PRWEB) October 28, 2021 InBios International Inc., a leading devel... |
| 15.09.2021 | InBios Receives FDA EUA for COVID-19 IgG Antibody Rapid Test | InBios SCoV-2 Detect IgG Rapid Test SEATTLE (PRWEB) September 15, 2021 InBios International Inc., a leading developer of diagnostic tests for emerging infectious diseases, announced today that it received Emergency Use Authorization (EUA) f... |
| 22.08.2021 | New Lab Studies Suggest InBios COVID-19 POC Antigen Detection Test Will Detect Delta Variant | SCoV-2 Ag Detect Rapid Test SEATTLE (PRWEB) August 22, 2021 InBios International Inc., a leading developer of diagnostic tests for emerging infectious diseases, announced today that laboratory studies suggest its SCoV-2 Ag Detect Rapid Test... |
| 12.05.2021 | InBios Receives FDA EUA for COVID-19 POC Antigen Detection Test | SCoV-2 Ag Detect Rapid Test SEATTLE (PRWEB) May 12, 2021 InBios International Inc., a leading developer of diagnostic tests for emerging infectious diseases, announced today that it received Emergency Use Authorization (EUA) from the U.S. F... |